Supha Pharmachem
0.88
-0.02(-2.22%)
Market Cap₹77.64 Cr
PE Ratio45.00
Company Performance:
1D-2.22%
1M+1.15%
6M-32.82%
1Y-64.94%
5Y+225.93%
View Company Insightsright
More news about Supha Pharmachem
11Aug 25
Remedium Lifecare Reports Stellar Q1 Results, Surpassing Previous Annual Profit
Remedium Lifecare, a pharmaceutical supply chain and specialty chemicals company, has reported outstanding Q1 financial results. The company's Profit After Tax (PAT) reached ₹464.88 lakh, more than doubling its entire previous annual profit. Revenue from Operations stood at ₹11,336.67 lakh, with Profit Before Tax (PBT) at ₹571.23 lakh. This marks a significant turnaround from the previous quarter's loss. The company attributes its success to operational efficiency and prudent financial management. Future plans include expanding R&D focus, building CDMO services, global expansion, and enhancing working capital management.
 no imag found
04Aug 25
Remedium Lifecare Reports Mixed Q1 Results: Consolidated Profit Amidst Standalone Loss
Remedium Lifecare Limited (RLL) announced its Q1 financial results, showing a consolidated profit of ₹4.65 crore despite a standalone loss of ₹36.51 lakh. Consolidated revenue from operations was ₹113.37 crore, while standalone revenue declined to ₹18.37 crore from ₹77.70 crore year-over-year. The subsidiary, Remlife Global PTE, significantly contributed to the group's positive financial outcome. The company's business activity falls within a single segment, and the results were reviewed by the Audit Committee and approved by the Board of Directors.
 no imag found
22Jul 25
Remedium Lifecare Expands Globally with Singapore Subsidiary, Secures ₹182.7 Crore Export Contract
Remedium Lifecare Limited has undertaken several strategic moves to strengthen its global presence. The company established a wholly-owned subsidiary in Singapore, secured a ₹182.70 crore export contract, completed a successful rights issue, formed a partnership with Jia Yu Lifesciences, and enhanced its quality control infrastructure. These initiatives aim to transition Remedium into a full-spectrum pharmaceutical solutions provider, expand its international footprint, and drive long-term growth.
 no imag found
Supha Pharmachem
0.88
-0.02
(-2.22%)
1 Year Returns:-64.94%
Industry Peers
Redington
251.45
(-1.35%)
MMTC
62.07
(-1.07%)
MSTC
464.25
(+0.87%)
Ravindra Energy
147.11
(-1.54%)
BN Agrochem
262.00
(+0.06%)
TCC Concept
439.90
(-3.11%)
Creative Newtech
648.75
(-1.33%)
The Yamuna Syndicate
28,099.00
(+0.00%)